Invasive Prostate Carcinoma — Trials

Invasive Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

440 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 139
Recruiting: 65
Ph III recruiting: 5
Growth YoY: —
Industry share: 4%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 31.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (72)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01949337	Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer	unknown	Phase 3	1,311	Alliance for Clinical Trials in OncologyOTHER	3	Sep 28, 2023	clinicaltrials
NCT02258087	HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.(PROMOBRA)	unknown	Phase 2 / Phase 3	50	National Institute of Oncology, HungaryOTHER	1